RCTs - PULSE - Leading the Precise Diagnosis and Treatment of Pan-vascular Intervention

FAVOR III China
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial

et al. Lancet. 2021 Nov 3;S0140-6736(21)02248-0. doi: 10.1016/S0140-6736(21)02248-0.
FAVOR III Europe/Japan
Comparison of Quantitative Flow Ratio and Conventional Pressure-wire Based Functional Evaluation for Guiding Coronary Intervention. A Randomized Clinical Non-inferiority Trial.

ClinicalTrials.gov Identifier: NCT03729739
FAVOR IV-QVAS
Quantitative Flow Ratio Guided Revascularization Strategy for Patients Undergoing Primary Valve Surgery With Comorbid Coronary Artery Disease.

ClinicalTrials.gov Identifier: NCT03977129

FAVOR III China